Cardio Diagnostics Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Meeshanthini V. Dogan, with a market cap of $5.4M.
Common questions about Cardio Diagnostics Holdings Inc.
Cardio Diagnostics Holdings Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026.
Cardio Diagnostics Holdings Inc. has approximately 9 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.